Italian Study for Congenital Platelet Disorders
NCT06691581 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-11-15
Summary
Inherited platelet disorders (IPD) are a heterogeneous group of rare bleeding diseases associated with a reduction of platelet number and/or function and with a bleeding tendency ranging from mild to severe. The frequency of inherited thrombocytopenias has been estimated to be 2.7/100,000 while the prevalence of inherited platelet function disorders is unknown, partly because they are frequently overlooked due to their difficult diagnosis.
Conditions
- Platelet Disorder
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Erica De Candia, MD · Fondazione Policlinico A. Gemelli IRCCS
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-15
- Primary Completion
- 2028-10-01
- Completion
- 2028-10-30
Countries
- Italy
Study Locations
More Related Trials
-
Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
NCT04735588 ·Status: UNKNOWN
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
NCT01510873 ·Status: COMPLETED
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
NCT03638817 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Constitutional Platelet Disease
NCT04419987 ·Status: UNKNOWN ·Phase: NA
-
ITP Registry and Accompanying Biospecimen Collection
NCT05152238 ·Status: RECRUITING
-
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT01196884 ·Status: UNKNOWN
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Anomalies of Dense Platelet Granules
NCT04095715 ·Status: COMPLETED
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
Research of Predictive Factors to Immune Thrombopenic Purpura
NCT01648556 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Biologic Characterization of Patients With ITP
NCT05694325 ·Status: RECRUITING ·Phase: NA
-
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717 ·Status: COMPLETED
-
Observatory of Immunological Thrombopenic Purpura in the Brest Region
NCT06556888 ·Status: RECRUITING
-
Platelet Glycoproteins in Inherited Thrombocytopathy: Association With Aggregation Studies and Bleeding Severity
NCT03648190 ·Status: UNKNOWN
-
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
NCT03102593 ·Status: COMPLETED ·Phase: PHASE2
-
A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone
NCT02050581 ·Status: TERMINATED
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229 ·Status: COMPLETED